Sale!

PLN Gene Cardiomyopathy hypertrophic type 18 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PLN Gene Cardiomyopathy Hypertrophic Type 18 Genetic Test is a specialized diagnostic tool designed to detect mutations in the PLN gene, which are associated with Hypertrophic Cardiomyopathy (HCM) Type 18. This condition is characterized by the thickening of the heart muscle, which can lead to heart failure and other serious complications. The test is particularly valuable for individuals with a family history of HCM or those exhibiting symptoms related to heart muscle dysfunction.

Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis of the PLN gene to identify specific genetic alterations that contribute to the development of this form of cardiomyopathy. The process involves collecting a DNA sample from the patient, usually through a blood draw, and then utilizing advanced genetic sequencing technologies to scrutinize the PLN gene for any mutations.

The cost of the PLN Gene Cardiomyopathy Hypertrophic Type 18 Genetic Test is 4400 AED. This investment covers the entire testing process, from sample collection to detailed genetic analysis and reporting. The results from this test can provide crucial information for the diagnosis, treatment planning, and management of hypertrophic cardiomyopathy, enabling personalized medical care and potentially improving patient outcomes.

Given the implications of identifying a genetic predisposition to HCM, patients are often advised to undergo genetic counseling before and after the test. This ensures they fully understand the potential outcomes and implications of the test results, including the impact on family members who may also be at risk.

Description

PLN Gene Cardiomyopathy Hypertrophic Type 18 Genetic Test

Components: PLN Gene Cardiomyopathy Hypertrophic Type 18 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cardiovascular Pneumology Disorders

Doctor: Cardiologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for PLN Gene Cardiomyopathy, hypertrophic, type 18 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PLN Gene Cardiomyopathy, hypertrophic, type 18 NGS Genetic DNA Test gene PLN

Test Details: PLN gene cardiomyopathy, hypertrophic, type 18 is a genetic condition that affects the heart muscle, leading to the development of hypertrophic cardiomyopathy (HCM). HCM is characterized by the thickening of the heart muscle, which can make it harder for the heart to pump blood effectively. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of PLN gene cardiomyopathy, hypertrophic, type 18, NGS genetic testing can identify mutations or variations in the PLN gene that are associated with the development of this specific type of cardiomyopathy. NGS genetic testing can provide valuable information for individuals and their healthcare providers regarding their risk of developing cardiomyopathy, as well as potential treatment options and management strategies. It can also help with genetic counseling and family planning, as the results of the test can provide insights into the likelihood of passing on the condition to future generations. It is important to note that genetic testing for PLN gene cardiomyopathy, hypertrophic, type 18 should be conducted under the guidance of a healthcare professional or genetic counselor, as they can help interpret the results and provide appropriate recommendations based on the individual’s specific circumstances.

Test Name	PLN Gene Cardiomyopathy hypertrophic type 18 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Cardiovascular Pneumology Disorders
Doctor	Cardiologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for PLN Gene Cardiomyopathy, hypertrophic, type 18 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PLN Gene Cardiomyopathy, hypertrophic, type 18 NGS Genetic DNA Test gene PLN
Test Details	PLN gene cardiomyopathy, hypertrophic, type 18 is a genetic condition that affects the heart muscle, leading to the development of hypertrophic cardiomyopathy (HCM). HCM is characterized by the thickening of the heart muscle, which can make it harder for the heart to pump blood effectively. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of PLN gene cardiomyopathy, hypertrophic, type 18, NGS genetic testing can identify mutations or variations in the PLN gene that are associated with the development of this specific type of cardiomyopathy. NGS genetic testing can provide valuable information for individuals and their healthcare providers regarding their risk of developing cardiomyopathy, as well as potential treatment options and management strategies. It can also help with genetic counseling and family planning, as the results of the test can provide insights into the likelihood of passing on the condition to future generations. It is important to note that genetic testing for PLN gene cardiomyopathy, hypertrophic, type 18 should be conducted under the guidance of a healthcare professional or genetic counselor, as they can help interpret the results and provide appropriate recommendations based on the individual’s specific circumstances.